Mariner’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Sell |
132,765
-47,607
| -26% | -$68.1K | ﹤0.01% | 3069 |
|
|
2025
Q1 | $289K | Buy |
180,372
+12,397
| +7% | +$19.9K | ﹤0.01% | 2657 |
|
|
2024
Q4 | $605K | Buy |
167,975
+37,564
| +29% | +$135K | ﹤0.01% | 2028 |
|
|
2024
Q3 | $743K | Buy |
130,411
+2,532
| +2% | +$14.4K | ﹤0.01% | 1832 |
|
|
2024
Q2 | $591K | Sell |
127,879
-158
| -0.1% | -$730 | ﹤0.01% | 1926 |
|
|
2024
Q1 | $1.05M | Hold |
128,037
| – | – | ﹤0.01% | 1469 |
|
|
2023
Q4 | $723K | Buy |
128,037
+1,546
| +1% | +$8.74K | ﹤0.01% | 1674 |
|
|
2023
Q3 | $235K | Sell |
126,491
-15,317
| -11% | -$28.5K | ﹤0.01% | 2377 |
|
|
2023
Q2 | $390K | Buy |
141,808
+13,814
| +11% | +$38K | ﹤0.01% | 1922 |
|
|
2023
Q1 | $402K | Sell |
127,994
-93
| -0.1% | -$292 | ﹤0.01% | 1833 |
|
|
2022
Q4 | $756K | Buy |
128,087
+2,683
| +2% | +$15.8K | ﹤0.01% | 1381 |
|
|
2022
Q3 | $1.1M | Sell |
125,404
-175
| -0.1% | -$1.54K | ﹤0.01% | 1007 |
|
|
2022
Q2 | $947K | Buy |
125,579
+549
| +0.4% | +$4.14K | ﹤0.01% | 916 |
|
|
2022
Q1 | $3.03M | Buy |
+125,030
| New | +$3.03M | 0.01% | 615 |
|